HSP90 inhibition drives degradation of FGFR2 fusion proteins: implications for t
- This topic has 0 replies, 1 voice, and was last updated 5 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
HSP90 inhibition drives degradation of FGFR2 fusion proteins: implications for treatment of cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/30067876
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.